– UK, London – The Board of MIGO Opportunities Trust plc (LON: MIGO) today announced the appointments of Lucy Costa Duarte and Ian Henderson to its Board as independent non-executive directors, effective from 1 November 2022.
“My fellow directors and I are delighted to welcome Lucy and Ian to the Board. We are very pleased to have appointed directors with extensive industry and investor relations expertise.” said Board Chairman, Richard Davidson.
Lucy and Ian also have joined the Audit Committee and the Management Engagement Committee.
About Lucy Costa Duarte
Lucy Costa Duarte is a specialist in marketing strategy and investor relations, working part-time for SV Health Investors, the managers of International Biotechnology Trust since 2016. Lucy was formerly a Schroders’ ECM team manager, specializing in Eastern Europe, the Middle East, Africa and Turkey until Schoders’ investment banking division was bought by Salomon Smith Barney in 2000 and then became Citigroup. At Citigroup, Lucy was a director heading the emerging markets ECM team in London which was successful in winning and executing equity offerings in Greece, South Africa, Poland, Russia, Hungary, Estonia, Israel, Dubai and Oman. Lucy left Citigroup in 2007 and spent the next decade raising three children. During this period, she undertook voluntary fundraising for the Motor Neurone Disease Association.
She holds a BA (Hons) in Modern Languages from the University of Durham.
About Ian Henderson
Ian Henderson is an advertising professional currently CEO of specialist agency AML, working with many firms in the finance sector including Vanguard, Barclays, and BNP Paribas in the UK and internationally. The agency has grown consistently and profitably throughout the past decade winning many awards for creativity and effectiveness. AML has recently been acquired by Selbey Anderson, the UK’s fastest-growing marketing services group, of which Ian is now also chief creative officer. Ian was formerly a creative director at Publicis Groupe then CEO of subsidiary Masius, where he turned the business around to deliver strong growth and margin. He left in 2008 to set up a new agency for Engine Group before leading an MBI to start AML in 2011. Ian co-founded impact investing platform The Big Exchange (with The Big Issue), genetic screening biotech Halo during the covid pandemic and is a creative consultant, writer, and broadcaster through IHC.
He holds a BA (Hons) in English from the University of Durham.
For more information: https://www.migoplc.co.uk/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
